STOCK TITAN

Silynxcom Ltd. (SYNX) 424B Filings

SYNX NYSE

Here are the 424B prospectus supplements from Silynxcom Ltd. (SYNX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow SYNX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SYNX filings page.

Rhea-AI Summary

Silynxcom Ltd. may sell ordinary shares with an aggregate offering price of up to $1,300,000 through an at-the-market program with ThinkEquity LLC. Sales may be made at market prices; negotiated transactions are also permitted if Silynxcom authorizes them in writing. ThinkEquity will use commercially reasonable efforts but is not required to sell a specified amount.

Silynxcom had 6,634,400 ordinary shares outstanding as of September 30, 2026. The number sold will depend on sale prices and company instructions; there is no minimum offering amount, and the parties may suspend sales upon proper notice and subject to agreement conditions. Silynxcom intends to use substantially all net proceeds for working capital and general corporate purposes.

ThinkEquity's commission is 3.0% of gross proceeds from each sale. Estimated offering expenses are approximately $49,155, excluding commissions and reimbursements. Silynxcom also agreed to reimburse specified expenses up to $45,000 upon execution, plus requested reimbursements capped at $6,000 semi-annually and $10,000 annually.